Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations

American Journal of Human Genetics

Volumn 76, Issue 1, 2005, Pages 42-51

  Bergametti, F ^a   Denier, C ^a,b   Labauge, P ^a,c   Arnoult, M ^a   Boetto, S ^d   Clanet, M ^e   Coubes, P ^f   Echenne, B ^g   Ibrahim, R ^h   Irthum, B ⁱ   Jacquet, G ^j   Lonjon, M ^k   Moreau, J J ⁱ   Neau, J P ^l   Parker, F ^m   Tremoulet, M ^d   Tournier Lasserve, E ^a,b,n  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c Service de Neurologie   (France)

^d Service de Neurochirurgie   (France)

^e Service de neurologie HÔpital Rangueil   (France)

^f Service de Neurochirurgie   (France)

^g service de neuropédiatrie   (France)

^h Service de Neurochirurgie   (France)

ⁱ Service de Neurochirurgie   (France)

^j Service de Neurochirurgie   (France)

^k Service de Neurochirurgie   (France)

^l Neuromodulation réseaux neuronaux unité fonctionnelle rachis neurostimulation service de neurochirurgie   (France)

^m Service de Neurochirurgie   (France)

ⁿ INSERM   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; BRAIN CAPILLARY; BRAIN HEMORRHAGE; CAVERNOUS HEMANGIOMA; CCM1 GENE; CCM2 GENE; CCM3 GENE; CELL LINE; CEREBRAL CAVERNOUS MALFORMATION; CHROMOSOME 3Q; CLINICAL ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; EXON; FAMILY; FEMALE; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENE EXPRESSION; GENE INDUCTION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE SEGREGATION; GENOME; GENOTYPE; HAMARTOMA; HUMAN; MALE; MARKER GENE; NEUROLOGIC DISEASE; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; NULL ALLELE; OPEN READING FRAME; PDCD10 GENE; PRIORITY JOURNAL; PROMYELOCYTE; RNA SPLICING; SEIZURE; SEQUENCE ANALYSIS;

INVERTEBRATA; VERTEBRATA;

EID: 19944394831     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/426952     Document Type: Article

References (25)

1. Busch CR, Heath DD, Hubberstey A (2004) Sensitive genetic biomarkers for determining apoptosis in the brown bullhead. Gene 329:1-10
2. Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, Steinberg GK, Ogilvy CS, Berg MJ, Crawford SC, Scott RM, Sabroe R, Kennedy CT, Mettler G, Beis MJ, Fryer A, Awad IA, Lifton RP (1998) Multilocus linkage identifies two new loci for a Mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet 7: 1851-1858
3. Denier C, Gasc JM, Chapon F, Domenga V, Lescoat C, Joutel A, Tournier-Lasserve E (2002) Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult. Mech Dev 117: 363-367
4. Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, Benabid AL, et al (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 74:326-337
5. Dubovsky J, Zabramski JM, Kurth J, Spetzler RF, Rich SS, Orr HT, Weber JL (1995) A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet 4:453-458
6. European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305-1315
7. Gunel M, Laurans MS, Shin D, DiLuna ML, Voorhees J, Choate K, Nelson-Williams C, Lifton RP (2002) KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci USA 99:10677-10682
8. Guzeloglu-Kayisli O, Amankulor NM, Voorhees J, Luleci G, Lifton RP, Günel M (2004) KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex. Neurosurgery 54:943-949
9. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, Welchman DP, Zipperlen P, Ahringer J (2003) Systematic functional analysis of the Caenorhabditis elegans using RNAi. Nature 421:231-236
10. Labauge P, Laberge S, Brunereau L, Levy C, Maciazek J, Tournier-Lasserve E (1998) Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Lancet 352:1892-1897
11. Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, Marechal E, Joutel A, Bach JF, Tournier-Lasserve E (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23:189-193
12. Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, Verlaan D, Balogun F, Hughes L, Leedom TP, Plummer NW, Cannella M, Maglione V, Squitieri F, Johnson EW, Rouleau GA, Ptacek L, Marchuk DA (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73:1459-1464
13. Otten P, Pizzolato GP, Rilliet B, Berney J (1989) 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie 35:82-83, 128-131
14. Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig-Rigamonti K, Knight JT, Spetzler RF (1988) Cerebral cavernous malformations: incidence and familial occurrence. N Engl J Med 319:343-347
15. Russel DS, Rubinstein LJ (1989) Pathology of tumors of the nervous system. 5th ed. Williams and Wilkins, Baltimore, pp 730-736
16. Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, Touchman JW, Gallione CJ, Lee-Lin SQ, Kosofsky B, Kurth JH, Louis DN, Mettler G, Morrison L, Gil-Nagel A, Rich SS, Zabramski JM, Boguski MS, Green ED, Marchuk DA (1999) Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8:2325-2333
17. Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA (1997) Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15:1043-1049
18. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines J, Martuza RL, MacDonald ME, Sizenger BR, Short MP, Buckler AJ, Gusella JF (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800
19. Uhlik MT, Abell AN, Johnson NL, Sun W, Cuevas BD, Lobel-Rice KE, Home EA, Dell'Acqua ML, Johnson G (2003) Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmostic shock. Nat Cell Biol 5:1104-1110
20. Verhoef S, Bakker L, Tempelaars AMP, Hesseling-Janssen ALW, Mazurcak T, Jozwiak S, Fois A, Bartalini G, Zonnenberg BA, van Essen AJ, Lindhout D, Halley DJ, van den Ouweland AM (1999) High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet 64:1632-1637
21. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA, et al (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187-192
22. Wang YG, Liu HT, Zhang YM, Ma DL (1999) cDNA cloning and expression of an apoptosis-related gene, human TFAR-15 gene. Science in China series C-life sciences 42:323-329
23. Whitehead KJ, Plummer NW, Adams J, Marchuk DA, Li DY (2004) Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131:1437-1448
24. Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA (2002) KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11:389-396
25. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC (2001) Interaction between krit1 and icap1α infers perturbation of integrin β1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10:2953-2960